CEO & Co-Founder, Rythm
Hugo Mercier is the Co-founder and CEO of Rythm, a neurotechnology company that builds products that sit at the intersection of neuroscience and advanced technology to enhance everyday human experiences. Passionate about unlocking the brain’s full potential, Hugo has assembled some of the most respected specialists in neuroscience and hardware to launch Dreem, the first active wearable to improve the quality of sleep. Hugo founded Rythm in 2014 while completing his degree in applied mathematics and computer science at the prestigious Ecole Polytechnique in Paris. He also attended University of California – Berkeley, where he focused on the entrepreneurial track.
Paediatric Infectious Diseases Specialist, Madrid
Dr Pablo Rojo is a Paediatric Infectious Diseases Specialist of Hospital 12 de Octubre, Madrid, Spain. He is also Associate Professor of Complutense University, from where he obtained his MD and PhD. He has been a member of the Board of the Spanish Society of Paediatric Infectious Diseases (SEIP) from 2010 to 2014. He is author and coauthor of over 80 peer reviewed scientific articles and book chapters. He has participated in many paediatric antiretroviral clinical trials and is part of the EPIICAL project pursuing novel therapeutics approaches for early treated HIV-infected children. He participates as a Technical advisor for Paediatric HIV for Spanish Government and also advises the WHO on worldwide HIV issues.
CEO & Co-Founder, NovaGray
Clémence Franc acts as NovaGray’s CEO and Co-founder. Prior to founding NovaGray, she worked for household names in the engineering, consulting and scientific fields (Deloitte, GE HealthCare, Colas) and developed a previous start – up in the field of radiation oncology. Clémence worked with 2 researchers from a top French cancer centre (Institut Gustave Roussy, Villejuif). Specialised in innovative technology research and development, she is responsible for establishing the company’s business model, commercial strategy, fundraising and key partnerships. Clémence holds an MSc. from the Ecole Speciale des Travaux Publics et de l’Industrie (ESTP Paris) and an MSc. in entrepreneurship from HEC (Paris)
CEO & Co-Founder, Beamline Diagnostics
Liberty Foreman is the CEO and co-founder of BeamLine Diagnostics. Liberty completed her PhD in 2015 at UCL in Clinical Data Analytics. Whilst studying she received a 2014 fellowship from the Software Sustainability Institute for her collaborative work between statisticians and clinicians. During her research she developed the algorithm behind BeamLine, and in early 2015 she and Dr. Katherine Oliver, a technical expert in the field of infrared spectroscopy, co-founded BeamLine Diagnostics. BeamLine Diagnostics aims to streamline the cancer diagnostic pathway but dramatically reducing the number of biopsy samples sent to pathology.
Consultant ENT Surgeon, Medical Director, Cupris Ltd
Julian has nearly twenty years’ experience as an ENT and thyroid surgeon.Alongside his work as a surgeon he is also the co-founder and Medical Director of Cupris Health. Cupris Health is a digital health company that exploits web and smartphone technology to improve healthcare communication. The Cupris system comprises a healthcare communications app and web app, in addition to smartphone connected medical devices. Their first device is a smartphone otoscope, for examining ears. They have also developed a smartphone ophthalmoscope for retinal examinations.
CEO & Founder, Ananda Devices
Dr Margaret Magdesian, BSc Pharmacology, PhD Biochemistry (University of São Paulo, Brazil), has over 15 years of experience in biopharmaceutical research. Tired of the slow, expensive and inefficient process of drug development, in collaboration with researchers from McGill University (Canada), she developed a new product to increase standardization, precision, and reproducibility of cellular assays. Recently, she launched a company called ANANDA Devices (www.AnandaDevices.com) to commercialize this product and stimulate other scientists to achieve reproducible and impactful results faster. Dr Magdesian’s innovation has the potential to dramatically accelerate the drug development cycle of new therapies for people that need it.
After a roller-coaster career as a pioneer of the smartphone industry – including co-founding Symbian in 1998 – David is now a full-time futurist speaker, analyst, commentator, and writer.
Having spent 25 years road-mapping and enabling the rapid growth in capability of smart mobile devices, I expect to spend the next 25 years road-mapping and enabling the emergence of increasingly smart human beings – humans that radically transcend legacy limitations. Both journeys involve many hard obstacles en route. His background is in designing, architecting, implementing, supporting, and avidly using smart mobile devices. This includes ten years with PDA manufacturer Psion PLC, ten more with smartphone operating system specialist Symbian Ltd, and three years as CTO (Technology Planning Lead) for Accenture Mobility.
Chief Science Officer, SENS Research Foundation
Dr. Aubrey de Grey is a biomedical gerontologist based Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based biomedical research charity that performs and funds laboratory research dedicated to combating the aging process. He is also Editor-in-Chief of Rejuvenation Research, the world’s highest-impact peer-reviewed journal focused on intervention in aging. He received his BA in computer science and Ph.D. in biology from the University of Cambridge. His research interests encompass the characterisation of all the accumulating and eventually pathogenic molecular and cellular side-effects of metabolism (“damage”) that constitute mammalian aging and the design of interventions to repair and/or obviate that damage.
Founder & CEO of Synap
Visiting Assistant Professor at MIT
Reader in Viral Oncology
Professor & Chair of Nanomedicine at The School of Pharmacy, University of London
Co-Founder, Lucky Iron Fish Project
Professor of Global Health & Humanitarian Affairs
Director; Centre for Human Development, Stem Cells and Regeneration; Professor of Musculoskeletal Science
Lecturer at The University of Manchester